Adragos Pharma, a global CDMO headquartered in Munich, Germany, has acquired Baccinex, a Swiss-based provider of aseptic fill-finish manufacturing. This acquisition significantly enhances Adragos’ sterile manufacturing capabilities and marks a pivotal step in the expansion of its global network. Terms of the transaction were not disclosed.    Baccinex, based in Courroux, Jura, Switzerland, provides sterile fill-finish processes for both liquid and lyophilized vials. Operating from its EU-GMP a...